Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 496-505

  Gao, Xiao Mei ^a   Perchellet, Elisabeth M ^a   Davis, Amy W ^a   Newell, Steven W ^a   Chen, Guilan ^a   Hua, Duy H ^a   Perchellet, Jean Pierre ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 HYDROXYCAMPTOTHECIN; 10,11 METHYLENEDIOXYCAMPTOTHECIN; CAMPTOTHECIN; DIMETHYLBENZ[A]ANTHRACENE; MEZEREIN; PHORBOL ESTER; TOPOTECAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; EPIDERMIS; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TOPICAL DRUG ADMINISTRATION; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CAMPTOTHECIN; DNA; DNA ADDUCTS; DNA TOPOISOMERASES, TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INDUCTION; ENZYME INHIBITORS; EPIDERMIS; FEMALE; MICE; ORNITHINE DECARBOXYLASE; SKIN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRADECANOYLPHORBOL ACETATE;

EID: 0029936213     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<496::AID-IJC13>3.0.CO;2-6     Document Type: Article

References (31)

1. AFLALO, E., IFTACH, S., SEGAL, S., GAZIT, A. and PRIEL, A., Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action. Cancer Res., 54, 5138-5142 (1994).
2. BAIRD, W.M., SEDGWICK, J.A. and BOUTWELL, R.K., Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis. Cancer Res., 31, 1434-1439 (1971).
3. BOUTWELL, R.K., The biochemistry of preneoplasia in mouse skin. Cancer Res., 36, 2631-2635 (1976).
4. BOWDEN, G.T. and BOUTWELL, R.K., Studies on the role of stimulated epidermal DNA synthesis in the initiation of skin tumors in mice by N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res., 34, 1552-1563 (1974).
5. CLIFFORD, A., MORGAN, D., YUSPA, S.H., SOLER, A.P. and GILMOUR, S., Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res., 55, 1680-1686 (1995).
6. DIGIOVANNI, J., Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63-128 (1992).
7. DIGIOVANNI, J., FISHER, E.P. and SAWYER, T.W., Kinetics of formation and disappearance of 7,12-dimethylbenz[a]anthracene:DNA adducts in mouse epidermis. Cancer Res., 46, 4400-4405 (1986).
8. FRENKEL, K., WEI, L. and WEI, H., 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radicals Biol. Med., 19, 373-380 (1995).
9. GALI, H.U., PERCHELLET, E.M., KLISH, D.S., JOHNSON, J.M. and PERCHELLET, J.P., Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int. J. Cancer, 51, 425-432 (1992).
10. GARDELLINI, E. and DURBAN, E., Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells. Biochem. J., 291, 303-307 (1993).
11. HASHIMOTO, H., CHATTERJEE, S. and BERGER, N.A., Mutagenic activity of topoisomerase I inhibitors. Proc. amer. Assoc. Cancer Res., 36, 442 (1995).
12. HENNINGS, H., BOWDEN, G.T. and BOUTWELL, R.K., The effect of croton oil pretreatment on skin tumor initiation in mice. Cancer Res., 29, 1773-1780 (1969).
13. HENNINGS, H., MICHAEL, D. and PATTERSON, E., Croton oil enhancement of skin tumor initiation by N-methyl-N′-nitro-N-nitrosoguanidine: possible role of DNA replication. Proc. Soc. exp. Biol. Med., 158, 1-4 (1978).
14. HSIANG, Y.-H., LIHOU, M.G. and LIU, L.F., Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res., 49, 5077-5082 (1989).
15. HWONG, C.-L., CHEN, M.-S. and HWANG, J., Phorbol ester transiently increases topoisomerase I mRNA levels in human skin fibroblasts. J. biol. Chem., 264, 14923-14926 (1989).
16. KINZEL, V., LOEHRKE, H., GOERTTLER, K., FURSTENBERGER, G. and MARKS, F., Suppression of the first stage of phorbol 12-tetradecanoate 13-acetate-effected tumor promotion in mouse skin by nontoxic inhibition of DNA synthesis. Proc. nat. Acad. Sci. (Wash.), 81, 5858-5862 (1984).
17. PANTAZIS, P., KOZIELSKI, A.J., VARDEMAN, D.M., PETRY, E.R. and GIOVANELLA, B.C., Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts. Oncol. Res., 5, 273-281 (1993).
18. PELLING, J.C. and SLAGA, T.J., Comparison of levels of benzo[a]pyrene diol epoxide diastereomers covalently bound in vivo to macromolecular components of the whole epidermis versus the basal cell layer. Carcinogenesis, 3, 1135-1141 (1982).
19. PERCHELLET, E.M., GALI, H.U., GAO, X.M. and PERCHELLET, J.P., Ability of the nonphorbol ester-type tumor promoter thapsigargin to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo. Int. J. Cancer, 55, 1036-1043 (1993).
20. 2+ ionophores A23187 and ionomycin to mimic some of the effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production, ornithine decarboxylase activity, and DNA synthesis in mouse epidermis in vivo. Cancer Res., 50, 5806-5812 (1990).
21. PERCHELLET, E.M. and PERCHELLET, J.P., Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo. Cancer Res., 49, 6193-6201 (1989a).
22. PERCHELLET, J.P. and PERCHELLET, E.M., Antioxidants and multistage carcinogenesis in mouse skin. Free Radicals Biol. Med., 7, 377-408 (1989b).
23. PERCHELLET, J.P., PERCHELLET, E.M., GALI, H.U. and GAO, X.M., Oxidant stress and multistage skin carcinogenesis. In: H. Mukhtar (ed.), Skin cancer: mechanisms and human relevance, pp. 145-180, CRC Press, Boca Raton, FL (1995).
24. POTMESIL, M., Camptothecins: from bench research to hospital wards. Cancer Res., 54, 1431-1439 (1994).
25. RYAN, A.J., SQUIRES, S., STRUTT, H.L., EVANS, A. and JOHNSON, R.T., Different fates of camptothecin-induced replication fork-associated double-strand DNA breaks in mammalian cells. Carcinogenesis, 15, 823-828 (1994).
26. SLAGA, T.J., Multistage skin tumor promotion and specificity of inhibition. In: T.J. Slaga (ed.), Mechanisms of tumor promotion, vol. 2, pp. 189-196, CRC Press, Boca Raton, FL (1984).
27. SLAGA, T.J., BOWDEN, G.T., SHAPAS, B.G. and BOUTWELL, R.K., Macromolecular synthesis following a single application of polycyclic hydrocarbons used as initiators of mouse skin carcinogenesis. Cancer Res., 34, 771-777 (1974).
28. cdc2/cyclin B. Cancer Res., 52, 1823-1829 (1992).
29. TSAO, Y.-P., RUSSO, A., NYAMUSWA, G., SILBER, R. and LIU, L.F., Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res., 53, 5908-5914 (1993).
30. WALL, M.E. and WANI, M.C., Camptothecin and taxol: discovery to clinic - 13th Bruce F. Cain Memorial Award Lecture. Cancer Res., 55, 753-760 (1995).
31. WEI, H., WEI, L., FRENKEL, K., BOWEN, R. and BARNES, S., Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer, 20, 1-12 (1993).